BUPRENORPHINE 2 MG TABLET SL
For 30 tablets
Pharmacies pay
$8.30 filed
30 × $0.27676 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$14.55 estimated
$8.30 + $1.25 (15%) + $5.00 fee per fill = $14.55
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
BUPRENORPHINE 2 MG TABLET SL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “buprenorphine”, “buprenorphine hcl” and “buprenorphine hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as tablet and its route as sublingual.
FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., PAI Holdings, LLC dba PAI Pharma and Actavis Pharma, Inc.
FDA’s Established Pharmacologic Class for it is Partial Opioid Agonist.
The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes); the FDA directory lists 11 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $8.30 for 30 tablets (30 × $0.27676 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · NADAC explanation codes
The 11 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Actavis Pharma, Inc. | 1 | $0.27676 per EA filed |
| Advagen Pharma Ltd | 1 | $0.27676 per EA filed |
| American Health Packaging | 1 | $0.27676 per EA filed |
| AvPAK | 1 | $0.27676 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $0.27676 per EA filed |
| Hikma Pharmaceuticals USA Inc. | 1 | $0.27676 per EA filed |
| Major Pharmaceuticals | 1 | $0.27676 per EA filed |
| PAI Holdings, LLC dba PAI Pharma | 1 | $0.27676 per EA filed |
| Rhodes Pharmaceuticals LLC | 1 | $0.27676 per EA filed |
| SpecGx LLC | 1 | $0.27676 per EA filed |
| Sun Pharmaceutical Industries, Inc. | 1 | $0.27676 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.27676 per EA filed |
All 13 NDCs, with labeler and price
- 00054-0176-13 · Hikma Pharmaceuticals USA Inc. · $0.27676 per EA · eff. 2026-09-23 filed
- 00121-1019-30 · PAI Holdings, LLC dba PAI Pharma · $0.27676 per EA · eff. 2026-09-23 filed
- 00228-3156-03 · Actavis Pharma, Inc. · $0.27676 per EA · eff. 2026-09-23 filed
- 00406-7012-03 · SpecGx LLC · $0.27676 per EA · eff. 2026-09-23 filed
- 00904-7154-04 · Major Pharmaceuticals · $0.27676 per EA · eff. 2026-09-23 filed
- 31722-0870-30 · Camber Pharmaceuticals, Inc. · $0.27676 per EA · eff. 2026-09-23 filed
- 42858-0501-03 · Rhodes Pharmaceuticals LLC · $0.27676 per EA · eff. 2026-09-23 filed
- 50268-0128-11 · not listed as a package in the FDA directory · $0.27676 per EA · eff. 2026-09-23 filed
- 50268-0128-15 · AvPAK · $0.27676 per EA · eff. 2026-09-23 filed
- 60687-0481-11 · not listed as a package in the FDA directory · $0.27676 per EA · eff. 2026-09-23 filed
- 60687-0481-21 · American Health Packaging · $0.27676 per EA · eff. 2026-09-23 filed
- 62756-0459-83 · Sun Pharmaceutical Industries, Inc. · $0.27676 per EA · eff. 2026-09-23 filed
- 72888-0182-30 · Advagen Pharma Ltd · $0.27676 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
18 other products in the NADAC file share an FDA nonproprietary name with BUPRENORPHINE 2 MG TABLET SL.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| BELBUCA 75 MCG FILM | $7.54173 per EA filed | $12.76277 per EA filed |
| BELBUCA 150 MCG FILM | $7.55761 per EA filed | $12.76277 per EA filed |
| BELBUCA 300 MCG FILM | $11.85628 per EA filed | $12.76277 per EA filed |
| BELBUCA 450 MCG FILM | $16.1142 per EA filed | $12.76277 per EA filed |
| BELBUCA 600 MCG FILM | $17.19033 per EA filed | $12.76277 per EA filed |
| BELBUCA 750 MCG FILM | $18.09899 per EA filed | $12.76277 per EA filed |
| BELBUCA 900 MCG FILM | $18.59055 per EA filed | $12.76277 per EA filed |
| BUPRENORPHINE 2 MG TABLET SL this page | $0.27676 per EA filed | We don’t know yet |
| BUPRENORPHINE 5 MCG/HR PATCH | $23.44849 per EA filed | $61.65324 per EA filed |
| BUPRENORPHINE 7.5 MCG/HR PATCH | $37.67882 per EA filed | $61.65324 per EA filed |
| BUPRENORPHINE 8 MG TABLET SL | $0.57141 per EA filed | We don’t know yet |
| BUPRENORPHINE 10 MCG/HR PATCH | $32.52934 per EA filed | $61.65324 per EA filed |
| BUPRENORPHINE 15 MCG/HR PATCH | $53.7821 per EA filed | $61.65324 per EA filed |
| BUPRENORPHINE 20 MCG/HR PATCH | $58.8288 per EA filed | $61.65324 per EA filed |
| BUTRANS 5 MCG/HR PATCH | $48.86594 per EA filed | $102.43317 per EA filed |
| BUTRANS 7.5 MCG/HR PATCH | $68.82197 per EA filed | $102.43317 per EA filed |
| BUTRANS 10 MCG/HR PATCH | $73.60023 per EA filed | $102.43317 per EA filed |
| BUTRANS 15 MCG/HR PATCH | $124.62313 per EA filed | $102.43317 per EA filed |
| BUTRANS 20 MCG/HR PATCH | $131.09389 per EA filed | $102.43317 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 13 NDCs’ NADAC prices is $0.27676 per EA filed.
Of the 34 other products in FDA’s Partial Opioid Agonist class priced per EA, 34 have a higher middle NADAC price and 0 a lower one. The one in the middle is BELBUCA 300 MCG FILM, at $11.85628 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 30 tablets?
- NADAC prices this product per EA, and the FDA NDC Directory lists 11 of its 13 NDCs (it does not list the other 2) as a tablet taken under the tongue (dosage form “TABLET”, route “SUBLINGUAL”), so one EA is one tablet. OpenBill counts a tablet or film taken under the tongue or against the cheek as an oral solid, like one that is swallowed. The card starts at 30 tablets, a common one-month supply of a once-a-day medicine; change it to match your prescription.